XOLAIR is FDA-approved for use in appropriate patients with Allergic Asthma and also appropriate patients with chronic idiopathic urticaria (CIU). XOLAIR dosing and frequency are different for Allergic Asthma and CIU patients. Review the dosing and administration instructions for the appropriate indication below by clicking on the tabs.

Be sure to provide and instruct patients to read the XOLAIR Medication Guide before starting treatment and before each subsequent treatment.

XOLAIR Dosing for Allergic Asthma

XOLAIR Dosing for CIU

XOLAIR Shipping and Storage

  • XOLAIR prefilled syringe should be shipped and stored under refrigerated conditions 2°C to 8°C (36°F to 46°F) in the original carton. Protect from direct sunlight.
  • XOLAIR vial should be shipped at a controlled ambient temperature (≤30°C [≤86°F]) and stored under refrigerated conditions (2°C to 8°C [36°F to 46°F]). 
  • Do not use XOLAIR beyond the expiration date stamped on the carton. To learn more, read the administration instructions

If the XOLAIR prescribed for a labeled indication was spoiled or unable to be administered, the Genentech Spoilage Replacement Program might be able to provide you with a new supply.*
*Subject to certain limitations and conditions. The Spoilage Replacement Program covers infused or injected Genentech products.

Additional Support

For additional resources for you and your staff related to Procurement, Distribution, Spoilage, and Reimbursement, visit Access Solutions. To learn if financial support is available for your patient, click here

Contact a Representative

Fill out a contact form to get in touch with a XOLAIR representative to find out more about XOLAIR.